One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-154490
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 6 |
Affiliation: University of Washington, Fred Hutch Cancer Center, BC Cancer Agency, Fulcrum Therapeutics (United States), Columbia University Irving Medical Center, City Of Hope National Medical Center, Oregon Health & Science University, Moffitt Cancer Center, Cleveland Clinic, New York University, Sarah Cannon, Tennessee Oncology, Stanford Medicine, Stanford University, Memorial Sloan Kettering Cancer Center, Mayo Clinic, Hackensack University Medical Center, University of Pittsburgh, Colorado Blood Cancer InstituteUpdates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
